Home

>

Stocks

>

Emami Limited

info-icon
The current prices are delayed, login to your account for live prices
Login

Emami Limited

EMAMILTD

BSE
NSE

Fast Moving Consumer Goods (FMCG) / Personal Care & Healthcare

Loading...

NSE / BSE (Incorporated March 11, 1983)

About

Emami Limited

Company Overview

Emami Limited is one of India's leading FMCG companies engaged in the manufacturing and marketing of personal care and healthcare products. The inception of Emami Group took place in the mid-seventies in West Bengal, when two childhood friends, R.S. Agarwal and R.S. Goenka left their corporate jobs with the Birla Group to set up Kemco Chemicals, a cosmetic manufacturing unit in Kolkata, in 1974.

Emami Limited was incorporated on March 11, 1983, with the name 'AMP Udyog Viniyog Limited'. Initially, R S Agarwal and R S Goenka set up a cosmetic manufacturing unit in Kolkata in 1974 under the name of Kemco Chemicals, a partnership firm. By 1995, Kemco Chemicals transformed into Emami Ltd. Following this, by 1998, after merging with Himani Ltd, Emami emerged as a prominent player in the FMCG sector.

Brand Portfolio and Products

Emami is engaged in manufacturing and marketing of personal care and healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm, and others. The company markets products under Navratna, Mentho Plus, Zandu Balm, Zandu Sonachandi, BoroPlus, Diamond Shine, Kesh King, Fair and Handsome, 7 Oils in One, Fast Relief, HE, The Man Company, Brillare, and Kesari Jivan brand names.

The company has a portfolio of over 300+ products based on ayurvedic formulations. In 1984, Emami launched its flagship brand, BoroPlus Antiseptic Cream, followed by successful brand extensions. BoroPlus became a leading product not only in India but also across international markets like Russia, Ukraine, and Nepal. The iconic Navratna Cool Oil, introduced in the 1990s, revolutionized the therapeutic cool oil segment in India.

The company has significantly expanded its portfolio through strategic acquisitions. In 2008, Emami acquired Zandu Pharmaceutical for ₹730 Crore. The company merged Zandu FMCG into Emami and raised ₹310 Crore through QIP. A German personal care brand Creme 21 was acquired by Emami for ₹100 Crore in February 2019. In March 2022, Emami acquired the Dermicool brand from Reckitt for ₹432 Crore (£43 million).

Global Presence and Manufacturing

Emami's operations comprise more than 60 countries, including SAARC, MENAP, SEA, Africa, Eastern Europe, and the CIS countries. The company operates manufacturing facilities in India and Bangladesh. It sells products in India and international markets, including MENAP, SEA, SAARC, CIS, Africa, and Eastern Europe. Emami Limited, the group's FMCG arm, expanded its footprint by establishing its first overseas manufacturing unit in Ghazipur, Bangladesh, in 2012.

Financial Performance

The company's market capitalization stands at ₹24,566 Crore. For the full year ended March 2025, net profit rose 11.46% to ₹806.46 Crore from ₹723.53 Crore in the previous year. Sales rose 6.46% to ₹3,809.19 Crore in the year ended March 2025, against ₹3,578.09 Crore in the previous year.

Key Financial Metrics (FY25):

- Net profit: ₹806.46 Crore (11.46% growth)

- Revenue: ₹3,809.19 Crore (6.46% growth)

- Q4 FY25 net profit: ₹162.17 Crore (8.91% growth). Q4 FY25 sales: ₹963.05 Crore (8.06% growth).

- Second interim dividend: ₹4 per equity share for FY25.

Business Performance (Q3 FY25):

- Domestic business grew by 9% with a healthy volume growth of 6%.

- EBITDA margin improved to 32.3% compared to 31.6% in Q3 FY24.

- Organized channels (modern trade, e-commerce, and institutional sales) now contribute 28.6% of domestic business.

Financial Strength

The company is almost debt-free. The company has a good return on equity (ROE) track record: 3 Years ROE 29.9%. The company has been maintaining a healthy dividend payout of 52.5%. The company shows annual revenue growth of 7%, pre-tax margin of 24%, and ROE of 29%. The company is debt free and has a strong balance sheet, enabling it to report stable earnings growth across business cycles.

Market Position and Recognition

Emami is part of multiple prestigious indices including BSE 500, BSE Fast Moving Consumer Goods, Nifty 500, BSE MidCap, Nifty FMCG, and several other major market indices. The company has established itself as a household name in India with its focus on natural and Ayurvedic formulations.

Leadership and Management

In the main management, R S Goenka is chairman and Harsh Vardhan Agarwal serves as Vice Chairman & Managing Director for Emami Ltd. Emami is headquartered in Kolkata, West Bengal, India. Promoter holding in Emami Ltd stands at 54.84% as of March 2025.

The company continues to focus on innovation and expansion, with strategic investments in digital channels and new product development to maintain its competitive edge in the rapidly evolving FMCG landscape.